RAPT Therapeutics (RAPT) Non-Current Assets: 2020-2024
Historic Non-Current Assets for Therapeutics (RAPT) over the last 5 years, with Sep 2024 value amounting to $5.9 million.
- Therapeutics' Non-Current Assets fell 53.37% to $5.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.9 million, marking a year-over-year decrease of 53.37%. This contributed to the annual value of $11.5 million for FY2023, which is 14.56% down from last year.
- According to the latest figures from Q3 2024, Therapeutics' Non-Current Assets is $5.9 million, which was down 12.22% from $6.7 million recorded in Q2 2024.
- Over the past 5 years, Therapeutics' Non-Current Assets peaked at $13.7 million during Q1 2023, and registered a low of $3.0 million during Q3 2021.
- Over the past 3 years, Therapeutics' median Non-Current Assets value was $11.9 million (recorded in 2022), while the average stood at $10.9 million.
- Per our database at Business Quant, Therapeutics' Non-Current Assets spiked by 290.80% in 2022 and then slumped by 53.37% in 2024.
- Therapeutics' Non-Current Assets (Quarterly) stood at $3.4 million in 2020, then soared by 67.99% to $5.7 million in 2021, then surged by 138.65% to $13.5 million in 2022, then declined by 14.56% to $11.5 million in 2023, then slumped by 53.37% to $5.9 million in 2024.
- Its Non-Current Assets stands at $5.9 million for Q3 2024, versus $6.7 million for Q2 2024 and $7.5 million for Q1 2024.